• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.

作者信息

Davies Forsman Lina, Bruchfeld Judith, Alffenaar Jan-Willem C

机构信息

Karolinska Institutet, Dept of Medicine, Unit of Infectious Disease, Stockholm, Sweden.

Karolinska University Hospital, Dept of Infectious Disease, Stockholm, Sweden.

出版信息

Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.00173-2017. Print 2017 Apr.

DOI:10.1183/13993003.00173-2017
PMID:28446561
Abstract
摘要

相似文献

1
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.治疗药物监测以预防氟喹诺酮类药物在结核病治疗中产生获得性耐药。
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.00173-2017. Print 2017 Apr.
2
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.00317-2017. Print 2017 Apr.
3
Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.直接观察治疗强化方案可预防台湾耐多药结核病患者对氟喹诺酮类药物产生获得性耐药。
Clin Infect Dis. 2013 Apr;56(7):1054-5. doi: 10.1093/cid/cis978. Epub 2012 Nov 21.
4
Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen.巴基斯坦耐多药结核病中氟喹诺酮类药物耐药情况及指南推荐标准化治疗方案的适用性
Int J Mycobacteriol. 2015 Sep;4(3):258-9. doi: 10.1016/j.ijmyco.2015.05.012. Epub 2015 Jun 21.
5
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones.结核分枝杆菌分离株对吡嗪酰胺和氟喹诺酮类药物的耐药性。
Lancet Infect Dis. 2017 Jan;17(1):24-25. doi: 10.1016/S1473-3099(16)30547-3.
6
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones - Authors' reply.结核分枝杆菌分离株对吡嗪酰胺和氟喹诺酮类药物的耐药性——作者回复
Lancet Infect Dis. 2017 Jan;17(1):25. doi: 10.1016/S1473-3099(16)30538-2.
7
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.莫桑比克中部的耐多药结核病：快速基因型药敏试验的作用
BMC Infect Dis. 2016 Aug 17;16:423. doi: 10.1186/s12879-016-1766-x.
8
How are we creating fluoroquinolone-resistant tuberculosis?我们是如何制造出耐氟喹诺酮类药物的结核病的？
Am J Respir Crit Care Med. 2009 Aug 15;180(4):288-9. doi: 10.1164/rccm.200906-0863ED.
9
Fluoroquinolones in multidrug-resistant tuberculosis.
Am J Respir Crit Care Med. 2004 Oct 15;170(8):920-1. doi: 10.1164/ajrccm.170.8.951.
10
Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.台湾某医学中心1995 - 2003年结核分枝杆菌复合群对氟喹诺酮类药物的耐药趋势
J Antimicrob Chemother. 2005 Dec;56(6):1058-62. doi: 10.1093/jac/dki353. Epub 2005 Oct 4.

引用本文的文献

1
Therapeutic drug monitoring in tuberculosis.结核病治疗药物监测。
Eur J Clin Pharmacol. 2024 Nov;80(11):1659-1684. doi: 10.1007/s00228-024-03749-8. Epub 2024 Sep 6.
2
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis.左氧氟沙星和莫西沙星在埃塞俄比亚耐多药结核病患者中的群体药代动力学及达标概率
Infect Drug Resist. 2022 Nov 28;15:6839-6852. doi: 10.2147/IDR.S389442. eCollection 2022.
3
Antibiotic Therapy for Prosthetic Joint Infections: An Overview.
人工关节感染的抗生素治疗：概述
Antibiotics (Basel). 2022 Apr 5;11(4):486. doi: 10.3390/antibiotics11040486.
4
A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.一种用于测量唾液中左氧氟沙星的移动微体积紫外/可见分光光度计。
J Antimicrob Chemother. 2021 Jan 19;76(2):423-429. doi: 10.1093/jac/dkaa420.
5
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study.尼泊尔现行方案标准化方案治疗耐多药结核病患者的治疗结果：回顾性单中心研究。
BMJ Open Respir Res. 2020 Aug;7(1). doi: 10.1136/bmjresp-2020-000606.
6
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.前瞻性评估使用集中式治疗药物监测（TDM）改善结核病患者氟喹诺酮类药物暴露的效果（PERFECT）：一项前瞻性多中心队列研究的研究方案。
BMJ Open. 2020 Jun 16;10(6):e035350. doi: 10.1136/bmjopen-2019-035350.
7
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.线性回归和贝叶斯方法在结核病患者莫西沙星治疗药物监测中的有限采样策略。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00384-19. Print 2019 Jul.
8
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019.氟喹诺酮类药物在 2019 年结核病治疗中的作用。
Drugs. 2019 Feb;79(2):161-171. doi: 10.1007/s40265-018-1043-y.
9
Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients.肺结核患者左氧氟沙星个体化给药的群体药代动力学模型和有限采样策略。
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01092-18. Print 2018 Dec.
10
Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity.俄罗斯伊尔库茨克地区HIV感染患者抗结核药物的药代动力学：重新定义药物活性
Eur Respir J. 2018 May 24;51(5). doi: 10.1183/13993003.00109-2018. Print 2018 May.